Evidence map›Paper›PMID 35094052›Full record

ArticleBrain : a journal of neurology2023

Frontostriatothalamic effective connectivity and dopaminergic function in the psychosis continuum.

Kristina Sabaroedin, Adeel Razi, Sidhant Chopra, Nancy Tran, Andrii Pozaruk, Zhaolin Chen, Amy Finlay, Barnaby Nelson, Kelly Allott, Mario Alvarez-Jimenez and 14 more

Open access · hybridAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Levodopa-induced dyskinesia: brain iron deposition as a new hypothesis.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2024
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 4 institutions in 2 countries.

Kristina SabaroedinTurner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, Victoria 3800, Australia.ORCID 0000-0003-3571-5180
Adeel RaziTurner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, Victoria 3800, Australia.
Sidhant ChopraTurner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, Victoria 3800, Australia.
Nancy TranTurner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, Victoria 3800, Australia.
Andrii PozarukMonash Biomedical Imaging, Monash University, Clayton, Victoria 3800, Australia.
Zhaolin ChenMonash Biomedical Imaging, Monash University, Clayton, Victoria 3800, Australia.
Amy FinlayTurner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, Victoria 3800, Australia.
Barnaby NelsonOrygen, Parkville, Victoria 3052, Australia.
Kelly AllottOrygen, Parkville, Victoria 3052, Australia.ORCID 0000-0002-0640-4634
Mario Alvarez-JimenezOrygen, Parkville, Victoria 3052, Australia.
Jessica GrahamOrygen, Parkville, Victoria 3052, Australia.
Hok P YuenOrygen, Parkville, Victoria 3052, Australia.
Susy HarriganDepartment of Social Work, Monash University, Victoria 3800, Australia.
Vanessa CropleyMelbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne & Melbourne Health, Parkville, Victoria 3010, Australia.
Sujit SharmaMonash Health, Dandenong, Victoria 3175, Australia.
Bharat SalujaMonash Health, Dandenong, Victoria 3175, Australia.
Rob WilliamsThe University of Melbourne, Parkville, Victoria 3010, Australia.
Christos PantelisMelbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne & Melbourne Health, Parkville, Victoria 3010, Australia.ORCID 0000-0002-9565-0238
Stephen J WoodOrygen, Parkville, Victoria 3052, Australia.
Brian O'DonoghueOrygen, Parkville, Victoria 3052, Australia.
Shona FranceyOrygen, Parkville, Victoria 3052, Australia.
Patrick McGorryOrygen, Parkville, Victoria 3052, Australia.
Kevin AquinoTurner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, Victoria 3800, Australia.
Alex FornitoTurner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, Victoria 3800, Australia.
The University of Melbourne · AUMonash University · AUMonash Health · AUWellcome Centre for Human Neuroimaging · GB

Funding

Australian Research Council FT130100589Charles and Sylvia Viertel Charitable FoundationNational Health and Medical Research Council 1050504
6 · The paper itself

Abstract

Dysfunction of fronto-striato-thalamic (FST) circuits is thought to contribute to dopaminergic dysfunction and symptom onset in psychosis, but it remains unclear whether this dysfunction is driven by aberrant bottom-up subcortical signalling or impaired top-down cortical regulation. We used spectral dynamic causal modelling of resting-state functional MRI to characterize the effective connectivity of dorsal and ventral FST circuits in a sample of 46 antipsychotic-naïve first-episode psychosis patients and 23 controls and an independent sample of 36 patients with established schizophrenia and 100 controls. We also investigated the association between FST effective connectivity and striatal 18F-DOPA uptake in an independent healthy cohort of 33 individuals who underwent concurrent functional MRI and PET. Using a posterior probability threshold of 0.95, we found that midbrain and thalamic connectivity were implicated as dysfunctional across both patient groups. Dysconnectivity in first-episode psychosis patients was mainly restricted to the subcortex, with positive symptom severity being associated with midbrain connectivity. Dysconnectivity between the cortex and subcortical systems was only apparent in established schizophrenia patients. In the healthy 18F-DOPA cohort, we found that striatal dopamine synthesis capacity was associated with the effective connectivity of nigrostriatal and striatothalamic pathways, implicating similar circuits to those associated with psychotic symptom severity in patients. Overall, our findings indicate that subcortical dysconnectivity is evident in the early stages of psychosis, that cortical dysfunction may emerge later in the illness, and that nigrostriatal and striatothalamic signalling are closely related to striatal dopamine synthesis capacity, which is a robust marker for psychosis.

Indexed as

Psychotic DisordersSchizophreniaDihydroxyphenylalanineDopamineHumansMagnetic Resonance ImagingNeural PathwaysDihydroxyphenylalanineDopaminefluorodopa F 18dopamineeffective connectivityfrontostriatalpsychosisschizophrenia

Identifiers

PMID35094052
PMCPMC9825436
OpenAlexW4210323562

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.